Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert B. Sims
Robert B. Sims
Seattle Genetics
Internal medicine
Oncology
Medicine
Brentuximab vedotin
CD30
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Trial-in-Progress: Frontline Brentuximab Vedotin and CHP (A+CHP) in Patients with Peripheral T-Cell Lymphoma with Less Than 10% CD30 Expression
2020
Blood
Deepa Jagadeesh
Robert B. Sims
Steven M. Horwitz
Show All
Source
Cite
Save
Citations (0)
Trial-in-Progress: Brentuximab Vedotin in Combination with Lenalidomide and Rituximab in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
2020
Blood
Nancy L. Bartlett
Christopher A. Yasenchak
Robert B. Sims
Grzegorz S. Nowakowski
Show All
Source
Cite
Save
Citations (2)
Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients
2020
Blood
Christopher A. Yasenchak
Rodolfo Bordoni
Dipti Patel-Donnelly
Timothy S. Larson
Jerome H. Goldschmidt
Ralph V. Boccia
Vivian Jean M. Cline
Mariana Sacchi
Andres Forero-Torres
Robert B. Sims
Jingmin Liu
Jonathan W. Friedberg
Show All
Source
Cite
Save
Citations (3)
1